ascopubs.org

Methotrexate, Doxorubicin, and Cisplatin Versus Methotrexate, Doxorubicin, and Cisplatin + Ifosfamide in Poor Responders to Preoperative Chemotherapy for Newly Diagnosed High ...

Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer JCOG0905 is a multicenter, open-label, multi-institutional, randomized trial ...
TipRanks on MSN

Kura Oncology announces first patient dosed in KOMET-017 clinical trial

Kura Oncology (KURA) and Kyowa Kirin Co. announced that the first patient has been dosed under the KOMET-017 clinical trial protocol ...
The New England Journal of Medicine

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma

Patients who have cutaneous squamous-cell carcinoma with high-risk features are at risk for recurrence after definitive local therapy. The benefit of systemic adjuvant therapy options has not been ...
ascopubs.org

Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B)

Bridging the Gap: Molecular Profiling to Guide Treatment Selection in Metastatic Pancreatic Cancer Eligible patients with advanced-stage EGFR exon20ins NSCLC were randomly assigned by 1:1 ratio to ...